188Re-P-829

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name188Re-P-829
Drug Alias NameP-829-[188Re]P829 TheratideRhenium-188-P829
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDiatide Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiatide Inc
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsPancreatic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A